Abstract. The immunological processes in type 1 diabetes and metabolic/inflammatory disorder in type 2 diabetes converge on common signaling pathway(s) leading to ß-cell death in these two diseases. The cytokine-mediated ß-cell death seems to be dependent on voltage-dependent calcium channel (VDCC)-mediated Ca 2+ entry. The Ca 2+ handling molecular networks control the homeostasis of [Ca 2+ ] i in the ß-cell. The activity and membrane density of VDCC are regulated by several mechanisms including G protein-coupled receptors (GPCRs). CaR is a 123-kDa seven transmembrane extracellular Ca 2+ sensing protein that belongs to GPCR family C. Tumor necrosis factor-α (TNF-α), is a cytokine widely known to activate nuclear factor-κB (NF-κB) transcription in ß-cells. To obtain a better understanding of TNF-α-induced molecular interactions between CaR and VDCC, confocal fluorescence measurements were performed on insulin-producing ß-cells exposed to varying concentrations of TNF-α and the results are discussed in the light of increased colocalization correlation coefficient. The insulin producing ß-cells were exposed to 5, 10, 20, 30, and 50 ng/ml TNF-α for 24 h at 37˚C. The cells were then immunolabelled with antibodies directed against CaR, VDCC, and NF-κB. The confocal fluorescence imaging data showed enhancement in the colocalization correlation coefficient between CaR and VDCC in ß-cells exposed to TNF-α thereby indicating increased membrane delimited spatial interactions between these two membrane proteins. TNF-α-induced colocalization of VDCC with CaR was inhibited by nimodipine, an inhibitor of L-type VDCC thereby suggesting that VDCC activity is required for spatial interactions with CaR. The 3-D confocal fluorescence imaging data also demonstrated that addition of TNF-α to RIN cells led to the translocation of NF-κB from the cytoplasm to the nucleus. Such molecular interactions between CaR and VDCC in tissues possibly provide control over Ca 2+ channel activity via direct protein-protein contact.
Introduction
The programmed cell death (apoptosis) of insulin producing ß-cells is a common characteristic of type 1 and type 2 diabetes mellitus. In type 1 diabetes, anti-ß-cell autoimmune reactions and associated inflammations lead to ß-cell death. In type 2 diabetes, the metabolic disorder is associated with the production of inflammatory cytokines in insulin-sensitive tissues leading to elevated levels of circulating inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). The immunological processes in type 1 diabetes and metabolic/inflammatory disorder in type 2 diabetes converge on common signaling pathway(s) leading to ß-cell death in these two diseases.
Cytokine-mediated ß-cell death seems to be dependent on voltage-dependent calcium channel (VDCC)-mediated Ca 2+ entry as suggested by the findings that blockers of L-type VDCC can suppress ß-cell apoptosis induced by IL-1ß (1, 2) or IFNγ plus TNF-α (3), and blockers of T-type VDCC can repress ß-cell apoptosis induced by a mixture of cytokines (4) . The L-type VDCC is a VDCC major subtype found in the ß-cells of most species and is expressed in all the primary ß-cells and insulin-secreting cell lines (5, 6) . The spatiotemporal regulation of [Ca 2+ ] i in the ß-cell is dependent upon the functioning of several molecular entities in which VDCCs play major roles (7) . VDCC activity and distribution within the cell are regulated by various molecular complexes such as Ca 2+ /calmodulin, G protein-coupled receptors (GPCRs), protein kinases, and inositol phosphates (5) . VDCC gene expression changes in response to several physiological stimuli and pathological conditions. Cytokine incubation can turn on the gene expression of CaV3 channels in mouse ß-cells (4) .
Calcium-sensing receptor (CaR) is a 123-kDa seven transmembrane extracellular Ca 2+ sensing protein that resides within caveolin-rich membrane domains and belongs to GPCR family C (8, 9) . CaR is activated by Ca 2+ , divalent and trivalent cations, polycations, amino acids, and polyamines (8, 10, 11) . CaR is also expressed in human islets and in human insulinoma cells (12) (13) (14) . The CaR protein regulates several cellular processes including gene expression, cell proliferation and differentiation, secretion, and apoptosis (8) . Although, the role of CaR in insulin secretion is still not fully understood, CaR may participate in ß-cell replication and differentiation, thus regulating nutrient-induced insulin secretion, and could, therefore, be a potential target for the treatment of diabetes (11, (13) (14) (15) (16) . The GPCRs interact with many other intracellular proteins in addition to G proteins, such as ion channels, chaperone and trafficking proteins, scaffolding and structural proteins, signaling proteins, and a regulator of G protein signaling (17) (18) (19) (20) . The C-terminus of the CaR has been shown to interact with and inactivate two inwardly rectifying K channels, Kir4.1 and Kir4.2, in the kidney that are expressed in the distal nephron (thick ascending limb of Henle and distal convoluted tubule) as well as other tissues (21) .
We showed previously that TNF-α can decrease intracellular Ca 2+ buffering capacity by decreasing the levels of a high affinity calcium-binding protein and thus increase the rate of ß-cell apoptosis in a transformed insulin-secreting ß-cell line, rat insulinoma (RIN) cells (22) . The same study also demonstrated that calcium influx in response to KCl and ionomycin is larger in RIN cells (ß-cells) that have been previously exposed to TNF-α (22) . TNF-α is a cytokine widely known to activate NF-κB transcription in ß-cells (23) (24) (25) . Cytokines can induce ß-cell apoptosis through the induction of signaling pathways that activate NF-κB (26) (27) (28) . NF-κB is usually stored in the cytosol in its inactive form, bound to the inhibitory unit IκBα, which prevents DNA binding and nuclear translocation. NF-κB activating agents initiate phosphorylation of IκBα, inducing polyubiquitination at multiple sites and tagging the subunit for degradation by a 26S proteosome complex (26) (27) (28) . To obtain a better understanding of TNF-α-induced molecular interactions between CaR (a GPCR) and VDCC (a voltage-gated channel) confocal fluorescence measurements were performed on insulin-producing ß-cells exposed to varying concentrations of TNF-α; the results are described herein and discussed in light of the colocalization correlation coefficient.
Materials and methods
Cell culture. Rat insulinoma cells, RINr 1046-38 (RIN), insulin-producing ß-cells, kindly provided by Dr Bruce Chertow (Veterans Administration Medical Center, Huntington, WV, USA), were grown on 25-mm diameter glass coverslips in six-well culture plates in a 5% CO 2 incubator at 37°C. The cell culture medium was RPMI-1640 supplemented with 10% (w/v) fetal bovine serum, 100 units/ml of penicillin, and 100 μg/ml of streptomycin (Invitrogen Corporation, Grand Island, NY, USA).
Treatment with TNF-α. After 5 days of culture, RIN cells were treated with 5, 10, 20, 30, and 50 ng/ml TNF-α (rat, recombinant; Chemicon International, Temecula, CA) directly added to the cell culture medium and the cells were allowed to grow for the next 24 h at 37°C.
Immunofluorescence labeling. RIN cells were washed thrice and fixed with Bouin solution (Sigma Chemical Company, St. Louis, MO, USA) for 30 min at room temperature. The cells were then washed thrice with phosphate-buffer saline (PBS) followed by dehydration with 50, 70, 95, and finally 100% ethanol (EtOH) in PBS. The cells were then rehydrated by using 100, 95, 70, and 50% EtOH, and finally 0% EtOH (i.e. PBS). The hydrated RIN cells were permeabilized with 0.2% Triton X-100 (Sigma Chemical Company) at room temperature for 10 min and again washed thrice with PBS. To block non-specific binding of antibodies, the RIN cells were first blocked thrice for 5 min each with the blocking buffer containing 2% bovine serum albumin (BSA) in PBS followed by blocking with 5% normal goat serum in blocking buffer for 30 min. The RIN cells were then treated for 1 h at room temperature with i) an affinity purified goat polyclonal antibody raised against a peptide mapping within a C-terminal cytoplasmic domain of CaR of human origin (Santa Cruz Biotechnology, Inc., USA) and ii) an affinity purified rabbit antibody (Anti-Cav1.2) raised against a peptide corresponding to residues 844-865 of rat L-type VDCC, Cav1.2 (α 1 C) (Alomone Labs Ltd, Israel) or iii) an affinity purified polyclonal antibody raised against a peptide mapping at the C-terminus of NF-κB of human origin (Santa Cruz Biotechnology) wherever needed (see Results). The concentrations of primary antibodies solutions were 1 μg/ml and the solutions were prepared in blocking buffer, centrifuged at 13000 x g for 10 min before use. Following primary antibody treatment, the cells were washed thrice with blocking buffer and then treated with 5 μg/ml of Alexa Fluor 488 goat anti-rabbit IgG and Alexa Fluor 546 donkey anti-goat IgG fluorescent secondary antibodies (Invitrogen, Molecular Probes, Eugene, OR, USA) for 1 h at room temperature. The cells were then washed thrice with blocking buffer and thrice with PBS and the coverslips were mounted onto glass slides using water soluble Fluoromont-G (SouthernBiotech, Birmingham, AL, USA).
Confocal fluorescence microscopy. The confocal fluorescence images were scanned on a Nikon TE2000U inverted fluorescence microscope equipped with a Nikon D-Eclipse C1 laser scanning confocal microscope system (Nikon Corp., USA). The z-series scans were performed at every micrometer up to a z-depth of 10 μm by using a Nikon 40 x 1.30 NA DIC H/N2 Plan Fluor oil immersion objective. The 488-nm excitation beam was generated with a Spectra-Physics (Mountain View, CA, USA) argon laser and the 543-nm excitation beam was provided with a Melles Griot (Carlsbad, CA, USA) Helium-Neon laser. The built-in Nikon EZ-C1 software and Metamorph 6 software (Universal Imaging Corp., USA) were used for confocal image acquisition and analyses.
Confocal image analysis and calculation of colocalization correlation coefficient of VDCC with CaR. The 3-D confocal images obtained were processed with Nikon EZ-C1 software as described above and imported into Metamorph 6 software for further analysis. In order to determine the colocalization of VDCC with CaR, the confocal images were color thresholded for green (VDCC) and red (CaR). The colocalization correlation coefficients were measured by using the Correlation 
Nuclear translocation of NF-κB induced by TNF-α.
The ratio of localization of NF-κB in nuclear to cytoplasmic regions was determined by measuring the integrated fluorescence intensities in the nuclear and cytoplasmic regions of 3-D confocal fluorescence images of RIN cells acquired by using the Nikon C-1 confocal system as described above, and further analysis of these images with Metamorph 6.
Results
The insulin producing ß-cells were exposed to 5, 10, 20, 30, and 50 ng/ml TNF-α for 24 h at 37˚C. The cells were then immunolabelled with antibodies directed against CaR and VDCC or NF-κB as described above in Materials and methods. . In order to provide a mathematical definition for this colocalization of CaR with VDCC and also to measure the degree of colocalization, the data presented in Fig. 1 were further analyzed by calculating the colocalization correlation coefficient (see Materials and methods) and the results are presented in Table I . In control RIN cells, the correlation coefficient was 0.2766 whereas in TNF-α-treated RIN cells at 5 and 30 ng/ml the correlation coefficient decreased by 25 and 17% respectively as compared to that in control RIN cells (Table I, column 3) . However, at 10, 20, and 50 ng/ml TNF-α, significant increases in the correlation coefficient by 28, 75, and 18% respectively, were observed (Table I , column 3). The data showed that at 20 ng/ml TNF-α, the correlation coefficient increased by 75% thereby indicating the maximum colocalization of CaR with VDCC. The theoretical range of values for the correlation coefficient was -1.0 to +1.0 wherein a value of 1.0 indicates a perfect correlation of data which would only occur in the case of two identical images or the complete colocalization of the two proteins, and a value of -1.00 indicates an inverse relationship In order to test whether TNF-α-induced colocalization of VDCC with CaR could be inhibited by the activity of L-type VDCC, the RIN cells were first incubated with 10 μM nimodipine (NIMO), an inhibitor of L-type VDCC, followed by incubation of RIN cells with no TNF-α (control) and 10 ng/ml TNF-α for 24 h at 37˚C. Fig. 3 shows the results for VDCC (left panel, in green), CaR (middle panel, in red) and merged images (right panel). The 3-D confocal fluorescence imaging data presented in Fig. 3 indicate that the addition of 10 μM NIMO inhibited the spatial interaction between CaR and VDCC both in control and in TNF-α-treated RIN cells since no yellow color was observed in the merged images (right panel). This finding is further supported by the results for the colocalization correlation coefficient measurement. As shown in Table I , the addition of 10 μM NIMO to control RIN cells resulted in a 35% decrease in the correlation coefficient and most importantly the pretreatment of RIN cells with 10 μM NIMO, followed by addition of 10 ng/ml TNF-α significantly inhibited the interaction between CaR and VDCC since the correlation coefficient result was 0.0000. This is further substantiated by the correlation plots in Fig. 4 that show CaR (red, on Y-axis) and VDCC (green, on Xaxis) for control and TNF-α-treated RIN cells and indicate the inhibitory effect of VDCC inhibitor NIMO on spatial interaction between CaR and VDCC, thereby suggesting that VDCC activity is required for spatial interactions.
In order to demonstrate that the addition of TNF-α leads to the translocation of NF-κB from the cytoplasm to the nucleus, the control and TNF-α-treated RIN cells were immunolabelled with antibody directed against the p65 subunit of NF-κB and the confocal immunofluorescence microscopy measurements were carried out as described in detail in Materials and methods. The 3-D confocal fluorescence images presented in Fig. 5 show that the addition of TNF-α to RIN cells led to the translocation of NF-κB from the cytoplasm to the nucleus. In order to accord a mathematical value to the nuclear translocation of NF-κB, the ratio of fluorescence intensities in the nuclear and cytoplasmic regions was calculated and the results are presented in Table II . These results indicate that the addition of TNF-α to RIN cells significantly increased the nuclear translocation of NF-κB as defined by a more than 3-fold increase in the fluorescence ratios. In the presence of 10 μM NIMO, the increase in the Table I . Effect of TNF-α on the colocalization correlation coefficient. ratio of NF-κB in the nucleus and cytoplasm was between 2-and 2.5-fold (Table II) .
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Discussion
The ß-cell uptake and metabolism of glucose leads to the closure of ATP-sensitive K + channels, depolarization of the plasma membrane, and subsequently, influx of Ca Table II also). Table II . Nuclear translocation of NF-κB induced by TNF-α. 
The fluorescence ratio is defined as: Integrated fluorescence intensity in nucleus / Integrated fluorescence intensity in cytoplasm. The NF-κB localization was determined by using immunofluorescence with a primary antibody against the p65 subunit of NF-κB and the secondary antibody was labeled with Alexa Fluor 488 (see Materials and methods for details). 2+ ] i triggers direct interaction between exocytotic proteins situated in the insulin-containing granule membrane and those localized in the plasma membrane that initiates the fusion of insulin-containing granules with the plasma membrane, i.e. insulin exocytosis (5, 31) . The regulation of VDCC activity in ß-cells is crucial to provide an optimal concentration of Ca 2+ in these cells. Dysfunctions in VDCC regulation can result in type 1 and type 2 diabetes.
In a cellular milieu, the protein-protein interactions provide the foundation for the formation of complex molecular architecture and networks that in turn constitute various cellular signaling pathways. The VDCC subunits not only form Ca 2+ conducting pores in the plasma membrane, but also interact with many other proteins to form complex molecular networks. In these networks, VDCCs no longer respond only to voltage depolarization but are also modulated by their interacting partners. The VDCC subunits can even function as nonchannel proteins by cross-talk with other signaling molecules. The immunoprecipitation of ω-CTX GVIA binding proteins by using antibodies directed against syntaxin or synaptotagmin shows protein-protein interaction between VDCC and exocytotic proteins (32, 33) . By using fluorescence microscopy along with deconvolution analysis it was shown that the expressed CaV1.3 subunit-enhanced green fluorescent protein (GFP) and enhanced blue fluorescent protein-syntaxin 1 were targeted to and colocalized in the ß-cell plasma membrane (34) . The confocal fluorescence microscopy results presented in Fig. 1 in the present study show that VDCCs interact with CaR in ß-cells exposed to TNF-α. This observation was further strengthened by the increase in the colocalization correlation coefficient as shown in Table I , that indicated a value of 175% in 20 ng/ml TNF-α-treated ß-cells as opposed to the control ß-cells. The correlation plots (see Fig. 2 ) showing interaction between red pixels representing CaR on the Y-axis and green pixels representing VDCC on the X-axis is another important visual demonstration of such protein-protein interactions induced by the inflammatory cytokine TNF-α in insulin producing ß-cells.
Cytokines can alter the phenotype of VDCC in ß-cells and it is tempting to investigate how cytokines selectively turn on the expression of ß-cell CaV3 channels in type 1 diabetes situation. VDCCs as a constituent of Ca 2+ handling molecular networks play a critical role in the spatio-temporal regulation of [Ca 2+ ] i in the ß-cell (7 signals in ß-cells can activate the transcription factor NF-κB, involved in the regulation of cell cycle and apoptosis (37) . TNF-α is a cytokine widely known to activate NF-κB transcription in ß-cells (23) (24) (25) . NF-κB is usually stored in the cytosol in its inactive form, bound to the inhibitory unit IκBα, which prevents DNA binding and nuclear translocation. NF-κB activating agents initiate phosphorylation of IκBα, inducing polyubiquitination at multiple sites and tagging the subunit for degradation by a 26S proteosome complex (23) (24) (25) . The confocal fluorescence microscopy data presented in Fig. 5 clearly indicate that TNF-α addition to RIN cells resulted in the increased translocation of NF-κB from the cytoplasm to the nucleus. This visual observation is further substantiated by the increase in the ratio of integrated fluorescence intensities of NF-κB in the nucleus and the cytoplasm (see Table II ) indicating a more than 3-fold increase in this ratio in TNF-α-treated ß-cells. The [Ca 2+ ] i is also an important indicator of cell viability (38) (39) (40) (41) . In normal physiological conditions, the proper regulation of [Ca 2+ ] i by various constituents of Ca 2+ handling networks maintains ß-cell growth, proliferation, and differentiation. However, in pathophysiological situations, the changes in the intracellular and/or extracellular environment can lead to dysregulation of [Ca 2+ ] i due to the altered functioning of the Ca 2+ handling molecular networks which can cause ß-cell death (3, 4, 35, 42) . It has been shown that the addition of interferon-γ and TNF-α increases high-voltage activated (HVA) Ca 2+ currents, markedly increasing the [Ca 2+ ] i and resulting in apoptotic death in insulin-secreting cell lines. In type 1 diabetes, the loss of pancreatic ß-cells occurs whereas in type 2 diabetes the progressive loss of ß-cell function as well as increased ß-cell apoptosis has been observed (43) . The hyperactivation of ß-cell VDCC plays an important role in ß-cell apoptosis (3, 4, 35, 42) . ß-cell VDCCs could therefore be potential therapeutic targets for the prevention of ß-cell apoptosis and necrosis during the development of diabetes.
The interaction between G proteins and VDCC that leads to the inhibition of VDCC is a well-characterized mechanism of VDCC regulation that is voltage-dependent and membrane delimited. The results presented in Table I and Figs. 3 and 4 further demonstrate that the interaction between CaR and VDCC is dependent upon VDCC activity since the addition of NIMO, a blocker of L-type VDCC, significantly reduced spatial interaction between CaR and VDCC and the pretreatment of ß-cells with NIMO followed by the application of 10 ng/ml TNF-α significantly abolished such molecular interaction as evidenced by the finding that the correlation coefficient value was 0 (see Table I , Figs. 3 and 4) . VDCC regulation by the direct membrane-delimited interaction with G protein leads to a positive shift in the voltage dependence and a slowing of channel activation (44) . In addition to the direct regulation of VDCC by G proteins, GPCR activation also initiates a number of intracellular signaling pathways such as i) activation or inhibition of adenylyl cyclase resulting in elevation or lowering in intracellular cAMP levels, and eventually increase or decrease in protein kinase A (PKA) activity, ii) phospholipase C activation, generation of diacylglycerol (DAG) and inositol-triphosphate (InsP3), DAG and InsP3-released Ca 2+ serving as endogenous activators of PKC, and iii) Gα i/o -or Go-mediated activation of tyrosine kinases. All these protein kinases regulate VDCC (45) , and [Ca 2+ ] i can directly modulate VDCC (46) . The activation of GPCR presumably involves conformational changes of the membrane-spanning helices that change the conformation of intracellular loops and C-terminus, and thereby promote activation of G proteins. The C-terminus of CaR is involved in a positively co-operative response to Ca 2+ (47) , and binding to a scaffold protein, filamin-A (48) . The CaR signals via Gα i , Gα q , and Gα 12/13 proteins. Several CaRinteracting proteins such as filamin, a potential scaffolding protein, potassium channels, signaling proteins, chaperone and trafficking proteins, and receptor activity modifying proteins (RAMPs) may lead to the regulatory functioning of CaR (17) (18) (19) (20) . GPCRs have four domains that are exposed to the intracellular space and that are available to interact with other proteins, three intracellular loops that connect transmembrane domains and the C-terminus. The intracellular loops may interact with G proteins as well as other proteins including proteins involved in signaling, such as the arrestins or spinophilin (10) . The C-terminus of the CaR has been shown to interact with and inactivate two inwardly rectifying K channels, Kir4.1 and Kir4.2, in the kidney that are expressed in the distal nephron as well as other tissues (21, (50) (51) (52) (53) (54) . The findings described in the present study further strengthen the premise that CaR is able to interact with VDCC spatially. The interaction of CaR with ion channels, including VDCCs, in tissues could allow control over channel activity through direct protein-protein contact.
